0001209191-18-005829.txt : 20180129
0001209191-18-005829.hdr.sgml : 20180129
20180129161735
ACCESSION NUMBER: 0001209191-18-005829
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180125
FILED AS OF DATE: 20180129
DATE AS OF CHANGE: 20180129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital VIII, LLC
CENTRAL INDEX KEY: 0001618789
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 18555703
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0822
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Fund VIII, L.P.
CENTRAL INDEX KEY: 0001618788
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 18555701
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vivo Capital Surplus Fund VIII, L.P.
CENTRAL INDEX KEY: 0001628048
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 18555702
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650 688 0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4085 CAMPBELL AVENUE, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-486-1416
MAIL ADDRESS:
STREET 1: 4085 CAMPBELL AVENUE, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-25
0
0001566044
Menlo Therapeutics, Inc.
MNLO
0001618789
Vivo Capital VIII, LLC
505 HAMILTON AVE, SUITE 207
PALO ALTO
CA
0
0
1
0
0001628048
Vivo Capital Surplus Fund VIII, L.P.
C/O VIVO CAPITAL VIII, LLC
505 HAMILTON AVE, SUITE 207
PALO ALTO
CA
0
0
1
0
0001618788
Vivo Capital Fund VIII, L.P.
505 HAMILTON AVE, SUITE 207
PALO ALTO
CA
0
0
1
0
Common Stock
2018-01-25
4
P
0
258432
17.00
A
258432
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2018-01-25
4
P
0
35686
17.00
A
35686
I
By Vivo Capital Surplus Fund III, L.P.
Common Stock
2018-01-29
4
C
0
2348550
A
2606982
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2018-01-29
4
C
0
324306
A
359992
I
By Vivo Capital Surplus Fund III, L.P.
Common Stock
2018-01-29
4
C
0
917559
A
3524541
I
By Vivo Capital Fund VIII, L.P.
Common Stock
2018-01-29
4
C
0
126703
A
486695
I
By Vivo Capital Surplus Fund III, L.P.
Series B Preferred Stock
2018-01-29
4
C
0
6335215
0.00
D
Common Stock
2348550
0
I
By Vivo Capital Fund VIII, L.P.
Series B Preferred Stock
2018-01-29
4
C
0
874817
0.00
D
Common Stock
324306
0
I
By Vivo Capital Surplus Fund III, L.P.
Series C Preferred Stock
2018-01-29
4
C
0
2475118
0.00
D
Common Stock
917559
0
I
By Vivo Capital Fund VIII, L.P.
Series C Preferred Stock
2018-01-29
4
C
0
341784
0.00
D
Common Stock
126703
0
I
By Vivo Capital Surplus Fund III, L.P.
Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of each of Vivo Capital Fund VIII, L.P. ("VCF") and Vivo Capital Surplus Fund VIII, L.P. ("VCSF"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Albert Cha, a director of the issuer, Frank Kung, Edgar Engleman, Chen Yu and Shan Fu are managing members of Vivo LLC and may be deemed to share voting and dispositive power over the securities held by VCF and VCSF. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock.
/s/ Albert Cha as a managing member of Vivo Capital VIII, LLC
2018-01-29
/s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Surplus Fund VIII, L.P.
2018-01-29
/s/ Albert Cha as a managing member of Vivo Capital VIII, LLC, the general partner of Vivo Capital Fund VIII, L.P.
2018-01-29